ZIOPHARM Oncology (ZIOP)
Add to Watchlists Create an AlertZIOP Key Stats
| Income Statement | |
| Revenue TTM | 0.80M |
| Revenue Quarterly YoY Growth | 0.00% |
| EPS Diluted TTM | -1.052 |
| EPS Diluted Quarterly YoY Growth | |
| Net Income TTM | -84.46M |
| Profitability | |
| Gross Profit Margin Quarterly | |
| Profit Margin Quarterly | -6400% |
| Dividend | |
| Dividend Yield | 0.00% |
| Payout Ratio TTM Pro | Go Pro |
| Current Valuation | |
| Market Cap | 143.73M |
| Enterprise Value | 93.92M |
| PE Ratio TTM | |
| PE 10 Pro | Go Pro |
| PEG Ratio | |
| Price / Book Value | 3.793 |
| Other | |
| Beta Pro | Go Pro |
| Debt to Equity Ratio | 0.00 |
| Free Cash Flow | -18.36M |
| Return on Equity | -132.5% |
ZIOP News
- Trading Radar for 05/20: Campbell Soup (CPB), TiVo (TIVO), Qihoo (QIHU), JA Sola... May 17
- Apple Hits App Milestone, U.S. Bancorp Execs Unload, and 3 More Hot Stocks May 16
- 5 Stocks Seeing Bullish Options Action May 16
- ZIOPHARM Offers Promising Nonclinical and Phase I Study Results of Ad-RTS-IL-12 ... May 16
- ZIOPHARM Announces Presentation of Promising Nonclinical and Phase I Study Resul... May 16
- 5 Stocks Under $10 Set to Soar May 16
- InPlay: ZIOPHARM announces poster presentation at the 2013 American Society for ... May 15
- ZIOPHARM Announces Poster Presentation at the 2013 American Society for Clinical... May 15
- ZIOPHARM ONCOLOGY INC Financials May 14
- ZIOPHARM Announces First Quarter Financial Results and Key Developments GlobeNewswire May 7
ZIOP Total Returns Comparison
This total returns chart shows the returns to an investor from both price appreciation and dividends (dividends are assumed to be reinvested). ZIOPHARM Oncology is down 63.64% over the last year vs S&P 500 Total Return up 28.68%, Threshold Pharmaceuticals down 14.52%, and United Therapeutics Corporation up 56.74%.
ZIOP Fundamentals
Fundamental analysis of a business involves analyzing its financial statements and health, its management and competitive advantages. The key financial statements of a company are the income statement, balance sheet and cash flow statement.
Cash Flow Statement View Statement
You may also be interested in these ZIOP related companies
Pro Ratings for ZIOP
Pro Report PDF for ZIOP
Download Pro Ratings, Key Stats, Performance Charts, Valuations, and Financials in an easy to print format.
Download ZIOP Pro Report PDF
Pro Strategies Featuring ZIOP
Did ZIOPHARM Oncology make it into our Pro Portfolio Strategies?
ZIOP Profile
Sector: Healthcare
Industry: Biotechnology
Other ZIOP Resources
- 13F Filings Whale Wisdom
- Call Transcripts Seeking Alpha
- Insider Trading Morningstar
- Institutional Ownership MSN Money
- SEC Filings SEC
Recent Quotes
| Symbol | Price | Chg | Chg % | Market Cap |
|---|---|---|---|---|
| ZIOP | 1.71 | -0.08 | -4.47% | 143.73M |
